Table 10.
Sarcoma | Patients, n | Neoadjuvant CT, n (%) | Adjuvant CT, n (%) | Adjuvant Hormone Therapy, n (%) |
---|---|---|---|---|
LG-ESS | 63 | 0 | 1 (2) | 35 (56) |
Adenosarcoma | 19 | 0 | 4 (21) | 5 (26) |
STUMP | 84 | 0 | 0 | 0 |
LMS | 7 | 0 | 3 (43) | 0 |
UTROSCT | 2 | 0 | 0 | 0 |
Embryonal RMS of uterine cervix | 35 | 5 (14) | 23 (66) | 0 |
Total | 210 | 5 (2) | 31 (15) | 40 (19) |
CT: chemotherapy; FST: fertility-sparing treatment; LG-ESS: low-grade endometrial stromal sarcoma; LMS: leiomyosarcoma; n: number; RMS: rhabdomyosarcoma; STUMP: smooth muscle tumor of uncertain malignant potential; UTROSCT: uterine tumor resembling ovarian sex cord tumor.